Nomura Asset Management CO LTD Obs Eva Sa Transaction History

Nomura Asset Management CO LTD

12 transactions

Quarter	Operation	Price Per share	shares change
Q4 2019 Feb 13, 2020	SELL	$2.48 - $8.1 $0 - $0	0 Closed
Q3 2019 Nov 13, 2019	BUY	$8.22 - $11.2 $0 - $0	0 New
Q2 2019 Aug 13, 2019	BUY	$10.05 - $14.25 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$11.82 - $14.48 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$11.82 - $14.48 $0 - $0	0 New
Q4 2018 Feb 12, 2019	BUY	$10.8 - $17.94 $0 - $0	0 New
Q3 2018 Nov 07, 2018	BUY	$10.92 - $18.18 $0 - $0	0 New
Q2 2018 Aug 03, 2018	BUY	$10.0 - $17.87 $0 - $0	0 New
Q1 2018 May 14, 2018	BUY	$9.36 - $15.22 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$8.48 - $12.0 $0 - $0	0 New
Q3 2017 Nov 13, 2017	BUY	$6.38 - $8.14 $0 - $0	0 New
Q2 2017 Aug 14, 2017	BUY	N/A	0

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.